spacer gif spacer gif spacer gif spacer gif Propose a workshop for 2011 spacer gif
 QUICK SEARCH:   [advanced]


spacer gif
     Home     Help     Feedback     Subscriptions     Archive     Search     Table of Contents    

First published online December 22, 2004


Journal of Cell Science 118, 101e (2005)
© The Company of Biologists Limited
This Article
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Related articles in JCS
Right arrow Similar articles in this journal
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Search for Related Content
Social Bookmarking
 Add to CiteULike   Add to Complore   Add to Connotea   Add to Del.icio.us   Add to Digg   Add to Reddit   Add to Technorati   Add to Twitter  
What's this?

In this issue

ER stress relief


In eukaryotic cells, the modification and folding of membrane and secreted proteins occurs in the endoplasmic reticulum (ER). Agents that interfere with these processes cause such proteins to accumulate in the ER, leading to ER stress. Geoff Werstuck and colleagues now show that valproate, a branched-chain fatty acid used to treat epilepsy, protects cells from the lipid accumulation and apoptosis associated with ER stress (see p. 89). The authors report that, although valproate increases the expression of ER chaperones in the human hepatic cell line HepG2, it does not directly protect these cells from ER stress by increasing protein folding capacity. Instead, valproate protects the ER from the cellular complications induced by stress by inhibiting glycogen synthase kinase 3 (GSK3). Other GSK3 inhibitors have similar effects, indicating that GSK3 plays a central role in the cellular responses to ER stress. Thus, small-molecule drugs that inhibit GSK3 could provide new treatments for disorders in which ER dysfunction is implicated, including Alzheimer's disease and type-1 diabetes mellitus.


Add to CiteULike CiteULike   Add to Complore Complore   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati   Add to Twitter Twitter    What's this?

Related articles in JCS:

Valproate protects cells from ER stress-induced lipid accumulation and apoptosis by inhibiting glycogen synthase kinase-3
Anna J. Kim, Yuanyuan Shi, Richard C. Austin, and Geoff H. Werstuck
JCS 2005 118: 89-99. [Abstract] [Full Text]  




This Article
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Related articles in JCS
Right arrow Similar articles in this journal
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Search for Related Content
Social Bookmarking
 Add to CiteULike   Add to Complore   Add to Connotea   Add to Del.icio.us   Add to Digg   Add to Reddit   Add to Technorati   Add to Twitter  
What's this?